Skip to main content

TriSalus Life Sciences, Inc.

TLSIW
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001826667

In the last 90 days, TriSalus Life Sciences, Inc. insiders filed 1 open-market purchase and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.

Other share classesTLSI

Holders of 5% or more of TLSIW

Holders whose latest Schedule 13D or 13G filing reports 5% or more of TriSalus Life Sciences, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of TriSalus Life Sciences, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on TriSalus Life Sciences, Inc., newest first.

No Schedule 13D or 13G filings on TriSalus Life Sciences, Inc. are on file.

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell TriSalus Life Sciences, Inc. shares, newest first.

Form 144 notices for TLSIW
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Dec 10, 20244:06 PM ETArjun DesaiBoard of Directors30.0K$135.0KDec 10, 2024UBS Financial Services IncSEC